Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200046/S047

Harmony Transcatheter Pulmonic Valve System

Medtronic, Inc. · Decision date Jan 16, 2026

FDA DECISIONP200046/S047

What did the FDA decide?

FDA records P200046/S047 as a supplement to PMA P200046, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jan 16, 2026.

FDA approval order statement

to implement a process change to manufacturing steps related to the capsule attach components of the delivery catheter system and a new capsule attach backup mold
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Jan 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P200046/S047
Regulatory pathway
PMA supplement
Product code
NPV
Decision code
OK30
Decision date
Jan 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulmonary valve prosthesis percutaneously delivered.

Product code
NPV
FDA device class
f

For the original device and its historical approval scope, see PMA P200046. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200046 · Original PMA

    Harmony TPV System

  2. P200046/S044 · Related supplement

    Harmony Transcatheter Pulmonary Valve

  3. P200046/S047 received

    Application receipt date recorded by FDA.

  4. P200046/S047 · FDA decision

    30-Day Notice

  5. P200046/S049 · Related supplement

    Harmony Transcatheter Pulmonary Valve

  6. P200046/S046 · Related supplement

    Harmony Delivery Catheter System (HARMONY-DCS)

  7. P200046/S045 · Related supplement

    Harmony Transcatheter Pulmonary Valve

  8. P200046/S050 · Related supplement

    Harmony Transcatheter Pulmonary Valve System

  9. P200046/S051 · Related supplement

    Harmony Transcatheter Pulmonary Valve

Timeline entries are records held by MedtechLedger for P200046. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200046

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA approvalMar 26, 2021FDA
Harmony TPV SystemP200046/S043
Medtronic, Inc.PMA supplementSep 5, 2025FDA
Medtronic, Inc.PMA supplementOct 23, 2025FDA
Medtronic, Inc.PMA supplementFeb 10, 2026FDA
Medtronic, Inc.PMA supplementFeb 11, 2026FDA
Medtronic, Inc.PMA supplementFeb 12, 2026FDA
Harmony TPV SystemP200046/S048
Medtronic, Inc.PMA supplementMar 6, 2026FDA
Medtronic, Inc.PMA supplementMar 24, 2026FDA
Medtronic, Inc.PMA supplementJun 1, 2026FDA
Harmony TPV SystemP200046/S052
Medtronic, Inc.PMA supplementSep 30, 2026FDA

Explore the linked device profile

Other records with product code NPV

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3576 Unocal Pl., Bldg. A, Santa Rosa, CA, 95403

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records